Home/Filings/4/0000899243-19-020827
4//SEC Filing

MELAS KYRIAZI THEO 4

Accession 0000899243-19-020827

CIK 0001751299other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:30 PM ET

Size

5.4 KB

Accession

0000899243-19-020827

Insider Transaction Report

Form 4
Period: 2019-07-31
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-07-31+93,53193,531 total
    Exercise: $7.67Exp: 2029-07-31Common Stock (93,531 underlying)
Footnotes (1)
  • [F1]33% of this option shall vest on July 11, 2020, with the remainder vesting in 2 equal annual installments thereafter, subject to Mr. Melas-Kyriazi's continued service on the board of directors through each such date. This grant was made in accordance with the Company's Non-Employee Director Compensation Policy.

Issuer

Kaleido Biosciences, Inc.

CIK 0001751299

Entity typeother

Related Parties

1
  • filerCIK 0001216078

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:30 PM ET
Size
5.4 KB